Affiliation: University of Washington
- A comparison of methamphetamine-dependent inpatients childhood attention deficit hyperactivity disorder symptomatologyCraig Jaffe
Department of Psychiatry and Behavioral Sciences, University of Washington, 12013 Pinehurst Way NE, Seattle, WA 98125, USA
J Addict Dis 24:133-52. 2005..All participants demonstrated significant reductions in psychiatric symptoms with abstinence. Methamphetamine-dependent individuals with ADHD symptoms are common and pose a significant treatment challenge...
- An open-label pilot study of risperidone in the treatment of methamphetamine dependenceCharles W Meredith
Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, USA
J Psychoactive Drugs 39:167-72. 2007..0 (SD = 8.4) to 51.8 (SD = 8.3; t = 2.7, p <.05), and positive symptom distress declined from a mean of 52.8 (SD =8.0) to 41.7 (SD = 8.6; t= 3.0, p <.05). Risperidone was well tolerated and associated with decreased MA use...
- Open trial of injectable risperidone for methamphetamine dependenceCharles W Meredith
From the Mental Health Service CWM, JPR, CAM, EVY, AK, LCF, Amt, and AJS, Center of Excellence in Substance Abuse Treatment and Education CAM, LCF, and AJS, VA Puget Sound Health Care System and Department of Psychiatry and Behavioral Sciences CWM, CJ, MC, LCF, Amt, and AJS, University of Washington, Seattle, WA
J Addict Med 3:55-65. 2009..However, these results are limited by the use of an open trial design with a high dropout rate. Risperidone deserves further study in controlled trials as a pharmacotherapy for MA dependence...
- The content and clinical utility of psychiatric advance directivesDebra S Srebnik
Department of Psychiatry and Behavioral Sciences, University of Washington, 325 Ninth Avenue, Seattle, WA 98104, USA
Psychiatr Serv 56:592-8. 2005..This paper provides the first systematic examination of the content and clinical utility of psychiatric advance directives, which are documents that specify treatment preferences in advance of periods of compromised decision making...
- Single dose of 24 milligrams of buprenorphine for heroin detoxification: an open-label study of five inpatientsKathleen Ang-Lee
Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, Washington 98195 6560, USA
J Psychoactive Drugs 38:505-12. 2006..Use of ancillary medications was minimal. This study suggests that a single high dose of buprenorphine can be used safely and effectively for inpatient detoxification...
- Implications of chronic methamphetamine use: a literature reviewCharles W Meredith
Department of Psychiatry and Behavioral Sciences, University of Washington, and VA Puget Sound Health Care System S 116 ATC, 1160 S Columbian Way, Seattle, WA 98108, USA
Harv Rev Psychiatry 13:141-54. 2005..Atypical antipsychotics may have some promise in this regard...